Allergic Rhinitis and its Impact on Asthma (ARIA)

Recommendations 841 Preface 842 Classification 843 Epidemiology and genetics 843 Allergens and trigger factors 843 Allergens 843 Pollutants 844 Aspirin intolerance 844 Mechanisms involved in allergic rhinitis 844 Comorbidity and complications 844 Asthma 844 Other comorbidities 845 Diagnosis and assessment of severity 845 History and general ear, nose and throat (ENT) examination 845 Diagnosis of allergy 845 Diagnosis of asthma 846 Assessment of severity of rhinitis 846 Management 846 Allergen avoidance 846 Medications 846 Allergen-specific immunotherapy: therapeutic vaccines for allergic diseases 848 Future potential treatment modalities 849 Practical guidelines for the treatment of allergic rhinitis and comorbidities 849 Development of guidelines for rhinitis 849 Availability of the treatment 850 Recommendations for the management of allergic rhinitis 850 Pharmacologic management of rhinitis 850 Pharmacologic management of conjunctivitis 850 Avoidance of allergens and trigger factors 850 Allergen-specific immunotherapy 850 Treatment of rhinitis and asthma 850 Pediatric aspects 851 Special considerations 851 Education 851 Prevention of rhinitis 851 Quality of life 851 The socioeconomic impact of asthma and rhinitis 851 ARIA in developing countries 852 Further needs and research 852 References 852

[1]  P. Nafstad [Health effects of outdoor air pollution]. , 2004, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[2]  J. Bousquet,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) , 2003 .

[3]  A. Chuchalin,et al.  Prevention of allergy and asthma: interim report. , 2000 .

[4]  A. Chuchalin,et al.  Prevention of Allergy and Asthma
Interim Report , 2000, Allergy.

[5]  D. Enarson,et al.  Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  C. Bachert,et al.  Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. , 2000, Rhinology.

[7]  J Bousquet,et al.  Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.

[8]  E. Meltzer,et al.  Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. , 2000, Pediatrics.

[9]  G. Canonica,et al.  Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. , 2000, The Journal of allergy and clinical immunology.

[10]  R. Bush,et al.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. , 1999, The New England journal of medicine.

[11]  I. Cockburn,et al.  Loss of work productivity due to illness and medical treatment. , 1999, Journal of occupational and environmental medicine.

[12]  J. Warner Primary sensitization in infants. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  D. Enarson,et al.  Cultural barriers to asthma management , 1999, Pediatric pulmonology.

[14]  R. Mösges,et al.  International Conference on Allergic Rhinitis in Childhood , 1999 .

[15]  F. Simons,et al.  Allergic rhinobronchitis: the asthma-allergic rhinitis link. , 1999, The Journal of allergy and clinical immunology.

[16]  S. Durham,et al.  Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.

[17]  J. Bousquet,et al.  Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. , 1999, The Journal of allergy and clinical immunology.

[18]  B. Lipworth Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.

[19]  O. V. van Schayck,et al.  Control of house dust mite in managing asthma , 1999, BMJ.

[20]  P. Gergen,et al.  Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. , 1999, The Journal of allergy and clinical immunology.

[21]  J. Bousquet,et al.  Comparison between nasal and bronchial inflammation in asthmatic and control subjects. , 1999, American journal of respiratory and critical care medicine.

[22]  M. Schatz Interrelationships between asthma and pregnancy: a literature review. , 1999, The Journal of allergy and clinical immunology.

[23]  B. Wüthrich,et al.  Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  D. Strachan,et al.  Respiratory symptoms and home environment in children: a national survey , 1999, Thorax.

[25]  B. Lipworth,et al.  24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids , 1999, Thorax.

[26]  T. Casale Pathogenic Factors and Therapeutic Options , 1999 .

[27]  A. Leff Immunobiology of Asthma and Rhinitis Pathogenic Factors and Therapeutic Options , 1999 .

[28]  M. Burr,et al.  Indoor air pollution and the respiratory health of children , 1999, Pediatric pulmonology. Supplement.

[29]  C E Reed,et al.  Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. , 1999, The Journal of allergy and clinical immunology.

[30]  M. Chapman,et al.  Control of house dust mite in managing asthma. Conclusions of meta-analysis are wrong. , 1999, BMJ.

[31]  I. Garrelds,et al.  Nasal hyperreactivity. , 1999, Rhinology.

[32]  R. Puy,et al.  Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials , 1998, BMJ.

[33]  T. Platts-Mills,et al.  Indoor versus outdoor allergens in allergic respiratory disease. , 1998, Current opinion in immunology.

[34]  S. Fineman,et al.  Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  S. Spector,et al.  Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  D. Strachan House dust mite allergen avoidance in asthma , 1998, BMJ.

[37]  P. Gøtzsche,et al.  House dust mite control measures in the management of asthma: meta-analysis , 1998, BMJ.

[38]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[39]  B. Lipworth,et al.  Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. , 1998, The Journal of allergy and clinical immunology.

[40]  A E Nel,et al.  Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. , 1998, The Journal of allergy and clinical immunology.

[41]  J. Bousquet,et al.  Local immunotherapy , 1998, Allergy.

[42]  J. Bousquet,et al.  Relationships between rhinitis and asthma , 1998, Allergy.

[43]  K C Barnes,et al.  The genetics and complexity of allergy and asthma. , 1998, Immunology today.

[44]  B. Lundbäck,et al.  Epidemiology of rhinitis and asthma. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[45]  J. Balmes,et al.  Subjects with seasonal allergic rhinitis and nonrhinitic subjects react differentially to nasal provocation with chlorine gas. , 1998, The Journal of allergy and clinical immunology.

[46]  M. Andersson,et al.  Effects of orally inhaled budesonide in seasonal allergic rhinitis. , 1998, The European respiratory journal.

[47]  [WHO position paper. "Allergen immunotherapy: therapeutic vaccines for allergic diseases"]. , 1998, Arerugi = [Allergy].

[48]  C. Mackay,et al.  Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.

[49]  E. Minshall,et al.  Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. , 1997, American journal of respiratory cell and molecular biology.

[50]  D. Strachan,et al.  Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[51]  J. Bousquet,et al.  Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. , 1997, American journal of respiratory and critical care medicine.

[52]  G. Canonica,et al.  Treatment of allergic diseases during pregnancy. , 1997, Journal of investigational allergology & clinical immunology.

[53]  D. Strachan,et al.  Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts , 1997, BMJ.

[54]  R. Naclerio Pathophysiology of perennial allergic rhinitis , 1997, Allergy.

[55]  C. Lemière,et al.  Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. , 1997, The European respiratory journal.

[56]  S. Lau,et al.  Indoor allergen exposure is a risk factor for sensitization during the first three years of life. , 1997, The Journal of allergy and clinical immunology.

[57]  J. Bousquet,et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. , 1997, The Journal of allergy and clinical immunology.

[58]  N. Roche,et al.  Allergic and nonallergic interactions between house dust mite allergens and airway mucosa. , 1997, The European respiratory journal.

[59]  J. Corren Allergic rhinitis and asthma: how important is the link? , 1997, The Journal of allergy and clinical immunology.

[60]  D. Malone,et al.  A cost of illness study of allergic rhinitis in the United States. , 1997, The Journal of allergy and clinical immunology.

[61]  Pertti Mutanen,et al.  The risk of occupational rhinitis , 1997, International archives of occupational and environmental health.

[62]  G. Lewith,et al.  Unconventional therapies in asthma: an overview , 1996, Allergy.

[63]  P. Norman Is there a role for immunotherapy in the treatment of asthma? Yes. , 1996, American journal of respiratory and critical care medicine.

[64]  D. Edelstein Aging of the Normal Nose in Adults , 1996, The Laryngoscope.

[65]  A. Foresi,et al.  Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. , 1996, The Journal of allergy and clinical immunology.

[66]  A. Saxon,et al.  Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. , 1996, The Journal of allergy and clinical immunology.

[67]  Simons Fe Learning impairment and allergic rhinitis. , 1996 .

[68]  J. Bousquet,et al.  Pathophysiology of allergic rhinitis. , 1996, International archives of allergy and immunology.

[69]  F. Simons Learning impairment and allergic rhinitis. , 1996, Allergy and asthma proceedings.

[70]  P. Barnes Is there a role for immunotherapy in the treatment of asthma? No. , 1996, American journal of respiratory and critical care medicine.

[71]  Deborah Jarvis,et al.  Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). , 1996, The European respiratory journal.

[72]  R. Pawankar,et al.  Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis. , 1995, American journal of respiratory and critical care medicine.

[73]  G. Canonica,et al.  Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. , 1995, The Journal of allergy and clinical immunology.

[74]  G. Canonica,et al.  ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. , 1995, International archives of allergy and immunology.

[75]  C. Prescott,et al.  Peak nasal inspiratory flow measurement: an investigation in children. , 1995, International journal of pediatric otorhinolaryngology.

[76]  U Ackermann-Liebrich,et al.  Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. , 1995, International archives of allergy and immunology.

[77]  A. Jones,et al.  The limitations of peak nasal flow measurement. , 1994, Clinical otolaryngology and allied sciences.

[78]  W. Morgan,et al.  Epidemiology of physician-diagnosed allergic rhinitis in childhood. , 1994, Pediatrics.

[79]  J. Bousquet,et al.  Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. , 1994, The Journal of allergy and clinical immunology.

[80]  F. Simons,et al.  The pharmacology and use of H1-receptor-antagonist drugs. , 1994, The New England journal of medicine.

[81]  P. Howarth,et al.  Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. , 1994, American journal of respiratory cell and molecular biology.

[82]  N. M. Kjellman,et al.  Natural course of asthma and allergy in childhood , 1994, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[83]  J. Neher,et al.  Health effects of outdoor air pollution. , 1994, American family physician.

[84]  U Keil,et al.  Self-reported wheezing and allergic rhinitis in children and traffic density on street of residence. , 1994, Annals of epidemiology.

[85]  P. Howarth,et al.  Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. , 1993, Journal of immunology.

[86]  J. Bousquet,et al.  HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. , 1993, The American review of respiratory disease.

[87]  P. Howarth,et al.  Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. , 1993, The European respiratory journal.

[88]  W. Busse,et al.  Increased airway inflammation with segmental versus aerosol antigen challenge. , 1993, The American review of respiratory disease.

[89]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[90]  F. Simons,et al.  Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. , 1993, The Journal of allergy and clinical immunology.

[91]  J. Bousquet,et al.  Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. , 1992, The Journal of allergy and clinical immunology.

[92]  P. Turkeltaub,et al.  The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). , 1992, The Journal of allergy and clinical immunology.

[93]  E. Pastorello,et al.  Clinical evaluation of CAP System and RAST in the measurement of specific IgE , 1992, Allergy.

[94]  W. Fokkens,et al.  Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non‐allergic controls: a biopsy study , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[95]  S. Durham,et al.  Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. , 1992, Journal of immunology.

[96]  S. Durham,et al.  Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. , 1992, The Journal of allergy and clinical immunology.

[97]  C. Irvin,et al.  Changes in bronchial responsiveness following nasal provocation with allergen. , 1992, The Journal of allergy and clinical immunology.

[98]  L. Calderón-Garcidueñas,et al.  Histopathologic changes of the nasal mucosa in southwest Metropolitan Mexico City inhabitants. , 1992, The American journal of pathology.

[99]  J. Dry,et al.  Allergy to latex , 1991, Clinical reviews in allergy.

[100]  B. Sibbald,et al.  Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. , 1991, Thorax.

[101]  F. Neukirch,et al.  Protective effect of theophylline on bronchial hyperresponsiveness in patients with allergic rhinitis. , 1991, The American review of respiratory disease.

[102]  G. Guyatt,et al.  Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[103]  M. Iversen,et al.  Epidemiology of house dust mite allergy , 1991, Allergy.

[104]  P. Turkeltaub,et al.  Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II). , 1991, Annals of allergy.

[105]  G. Scadding,et al.  Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. , 1990, Rhinology.

[106]  R. Dahl,et al.  Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma , 1990, Allergy.

[107]  J. Bousquet,et al.  Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. , 1990, The Journal of allergy and clinical immunology.

[108]  N. Eriksson,et al.  Allergy screening with Phadiatop and CAP Phadiatop in combination with a questionnaire in adults with asthma and rhinitis. , 1990, Allergy.

[109]  M. Bende,et al.  Nasal congestion during pregnancy. , 1989, Clinical otolaryngology and allied sciences.

[110]  U. Pipkorn,et al.  Nasal mucosal blood flow after intranasal allergen challenge. , 1988, The Journal of allergy and clinical immunology.

[111]  U. Pipkorn,et al.  Hay fever: in the laboratory and at natural allergen exposure , 1988, Allergy.

[112]  U. Ryo,et al.  Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. , 1975, The Journal of allergy and clinical immunology.